Location:
Amsterdam
/
Netherlands
Solvency II is hanging over the insurance industry like the sword of Damocles, promising a violent reshaping of the whole industry. But will the change be truly as dramatic as prophesied?
“Wait and see” is becoming the new attitude of the insurers, they are waiting for the regulatory debate to settle before finalising design, at the same time they are still trying to maintain a proactive stance to avoid back loading all development. Is 1 January 2014 going to be the final implementation date? Can Solvency II prevent another economic crisis or are we going to see Solvency III soon?
Event Focus
• Get the latest updates on the current state of Solvency II
• Find out what you do not know about the three Pillars yet
• Compare your preparedness with other major insurers
• Get ...
Location:
United States
CHI's PepTalk: The Protein Science Week is more than just a conference. It is a community dedicated to the evolving field of biotherapeutics and a gateway to the future of biologics. The continuous growth and success of PepTalk is due to the commitment and quality of scientific programming.
Join us January 21-25 in Palm Springs, California to learn about the advances and debate the challenges in protein-based therapeutics.
ExL Pharma is pleased to offer the 3rd Developing CAPAs in the GCP Environment Conference, taking place January 24-25 in Arlington, VA. As the ONLY forum dedicated to clinical corrective and preventive actions, this event has become the annual gathering for clinical quality and operations professionals from companies of all sizes and types to discuss and share their experiences with understanding, defining, developing and implementing clinical CAPAs.
The 5th Risk Evaluation and Mitigation Strategies Summit brings together executives from the industry to prepare for the changing landscape of REMS. As the 5th year anniversary of the FDAA Act of 2007, which mandated the implementation of REMS, arrives and brings forth new challenges, stay ahead of the curve and learn cutting-edge strategies and innovative techniques to ensure that your drugs are staying compliant while ensuring accessibility and success in the market.
By attending this year’s event, you will benefit from one of the only conferences focused specifically on REMS and the strategies on how to design and implement a thorough risk management program that meets FDA regulations. Hear from experienced professionals the best practices to create a successful REMS assessment and ...
The reauthorization of the Prescription Drug User Fee Act (PDUFA V) came into effect for all New Drug Applications (NDA) submitted on or after October 1, 2012. Pharmaceutical companies are scrambling to fully understand the new PDUFA V mandates for a successful first-cycle review under "The Program".
Gain NDA Approval Under PDUFA V fills that knowledge gap by bringing together key regulatory stakeholders to discuss the obligations, implementation plans, and impact PDUFA V, Specifically the NME and e-submission review process enhancements, will have on the New Drug Applications.
At this interactive conference, you will learn how the substantial changes of PDUFA V will shake up the industry – most notably how the NME/BLA provisions affect planning and understand the trade-...
Improving Quality in your TMF Documentation through a Compliant Centralized Filing System
During the clinical trials phase of a products’ life cycle involving patients, the pharmaceutical industry is required to create and maintains a trial master file (TMF) comprised of upwards of 100s of thousands and even approach 1 million in longer trials of required clinical documentations. These documents are designed to demonstrate compliance to an investigator or sponsor, and to maintain Good Clinical Practice standards.
Currently through a demand to improve TMF quality, the industry is making a transformation from eTMF had become easier for an organization to create a centralized eTMF system that is affordable, flexible, and can act as a real-time trial monitoring tool. eTMFs have also ...
Call for Papers
2013 Bangkok International Conference on Social Science - BICSS 2013
25-27 January 2013- Bangkok, Thailand
www.bicss.org
2013 Bangkok International Conference on Social Science - BICSS 2013 is the premier forum for the presentation of new advances in the fields of theoretical, experimental, and applied Social Science. The conference will bring together leading researchers, engineers and scientists in the domain of interest from around the world.
Submission Deadlines
Deadline for submission of abstracts/ full papers: October 15 2012
Notification of Acceptance/Rejection: November 1 2012
Deadline for full conference registration payment for all presenters:
November 26 2012
BICSS Conference: ...
On the 4th and 5th March 2013, Oliver Kinross will host The Myanmar International Trade and Investment Summit; a not-to-be-missed event for any international company looking to do business in the New Myanmar. The event will take place in Myanmar's capital Yangon.
China International Trenchless Technology & Tunnel and Underground Space Equipment Exhibition (TTUS 2013) is a special and unique trenchless, tunnel and underground space construction exhibition in China. Especially, TTUS is becoming the most effective trenchless exhibition in South China with the support from China Municipal Engineering Association and China Guangdong Society of Trenchless Technology. The staging of TTUS is particularly relevant and timely for many China engineers wishing to get up-to-date on the latest technology and products. We are looking forward your attendance.
Free EIN Membership Includes:
- Track news from thousands of sources
- Submit news sources for inclusion in our news tracking algorithm
- Build your own customized email newsletters
- Use of our RSS Feeds
- Includes a complimentary EIN Presswire account plus 1-free release
- Uncluttered & advertising free news pages